SWOT analysis of Daiichi Sankyo analyses the brand/company with its strengths, weaknesses, opportunities & threats. In Daiichi Sankyo SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.
SWOT Analysis is a proven management framework which enables a brand like Daiichi Sankyo to benchmark its business & performance as compared to the competitors and industry. Daiichi Sankyo is one of the leading brands in the pharma and healthcare sector. The table below also lists the top Daiichi Sankyo competitors and elaborates Daiichi Sankyo market segmentation, target group, positioning & Unique Selling Proposition (USP).
| Daiichi Sankyo Brand Analysis | |
|---|---|
| Parent Company |
Daiichi Sankyo |
| Category |
Pharmaceutical |
| Sector | |
| Tagline/ Slogan |
Passion for innovation, Compassion for patients |
| USP |
It is one of the largest pharmaceutical company in Japan |
| Daiichi Sankyo STP | |
| Segment |
Oncology & Cardiovascular diseases |
| Target Group |
Healthcare professionals offereing treatments to patients suffering from cancer or cardiovascular disease |
| Positioning |
They are global pharma innovator who aim to provide pharmaceuticals in shortest possible time |
| Daiichi Sankyo SWOT Analysis | |
| Strengths |
Below is the Strengths, Weaknesses, Opportunities & Threats (SWOT) Analysis of Daiichi Sankyo. Strengths are: 1. Has a strong workforce of over 30,000 employees 2. Leading producer of Benicar which is angiotensin II receptor antagonist 3. It is one of the largest pharmaceutical company in Japan 4. Strong presence in US, Europe, India, China, Brazil, Thailand and some others |
| Weaknesses |
Here are the weaknesses in the Daiichi Sankyo SWOT Analysis: 1. Despite being a strong brand, had a limited market share due to international competitors 2. Operates in limited segments such as Oncology & Cardiovascular segment |
| Opportunities |
Following are the Opportunities in Daiichi Sankyo SWOT Analysis: 1. Increasing world population and more awareness about health 2. More people suffering from chronic diseases such as cancer, cardiovascular diseases 3. Increasing awareness of healthcare solutions |
| Threats |
The threats in the SWOT Analysis of Daiichi Sankyo are as mentioned: 1. Natural disasters in Japan 2. increasing stringency in drug development guidelines 3. Global economic slowdown |
| Daiichi Sankyo Competition | |
| Competitors |
Below are the top 4 Daiichi Sankyo competitors: 1. Takeda Pharmaceuticals 3. Astellas pharmaceuticals 4. AstraZeneca |
The brandguide table above concludes the Daiichi Sankyo SWOT analysis along with its marketing and brand parameters.
Similar analysis has also been done for the competitors of the company belonging to the same category, sector or industry. Browse marketing analysis of more brands and companies similar to Daiichi Sankyo. The BrandGuide section covers SWOT Analysis, USP, STP & Competition of more than 6000 brands from over 20 categories. This SWOT and marketing analysis has been researched & authored by our BrandGuide Research Team members.
Search & Explore : BrandGuide
Write for Us!
Quizzes & Skills!
Quizzes test your expertise in business and Skill tests evaluate your management traits
Related Business Content
Top Companies Lists
All Sections on MBASkool
